Cargando…

Chromosome translocations: a biomarker for retrospective biodosimetry.

We discuss here the results from our studies demonstrating that simple translocations detected by chromosome painting can be used to reconstruct radiation doses for workers exposed within the dose limits and for individuals with past exposure. To be useful, a biomarker for exposure and risk assessme...

Descripción completa

Detalles Bibliográficos
Autor principal: Lucas, J N
Formato: Texto
Lenguaje:English
Publicado: 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1469918/
https://www.ncbi.nlm.nih.gov/pubmed/9467057
_version_ 1782127712737951744
author Lucas, J N
author_facet Lucas, J N
author_sort Lucas, J N
collection PubMed
description We discuss here the results from our studies demonstrating that simple translocations detected by chromosome painting can be used to reconstruct radiation doses for workers exposed within the dose limits and for individuals with past exposure. To be useful, a biomarker for exposure and risk assessment should employ an end point that is highly quantitative, stable over time, and relevant to human risk. Recent advances in chromosome staining using fluorescence in situ hybridization facilitate fast and reliable measurement of simple translocations, a type of DNA damage linked both to prior clastogenic exposure and to risk. In contrast to other biomarkers available, the frequency of simple translocations in individuals exposed to whole-body radiation is stable over time postexposure, has little interindividual variability, and can be measured accurately at low frequencies.
format Text
id pubmed-1469918
institution National Center for Biotechnology Information
language English
publishDate 1997
record_format MEDLINE/PubMed
spelling pubmed-14699182006-06-01 Chromosome translocations: a biomarker for retrospective biodosimetry. Lucas, J N Environ Health Perspect Research Article We discuss here the results from our studies demonstrating that simple translocations detected by chromosome painting can be used to reconstruct radiation doses for workers exposed within the dose limits and for individuals with past exposure. To be useful, a biomarker for exposure and risk assessment should employ an end point that is highly quantitative, stable over time, and relevant to human risk. Recent advances in chromosome staining using fluorescence in situ hybridization facilitate fast and reliable measurement of simple translocations, a type of DNA damage linked both to prior clastogenic exposure and to risk. In contrast to other biomarkers available, the frequency of simple translocations in individuals exposed to whole-body radiation is stable over time postexposure, has little interindividual variability, and can be measured accurately at low frequencies. 1997-12 /pmc/articles/PMC1469918/ /pubmed/9467057 Text en
spellingShingle Research Article
Lucas, J N
Chromosome translocations: a biomarker for retrospective biodosimetry.
title Chromosome translocations: a biomarker for retrospective biodosimetry.
title_full Chromosome translocations: a biomarker for retrospective biodosimetry.
title_fullStr Chromosome translocations: a biomarker for retrospective biodosimetry.
title_full_unstemmed Chromosome translocations: a biomarker for retrospective biodosimetry.
title_short Chromosome translocations: a biomarker for retrospective biodosimetry.
title_sort chromosome translocations: a biomarker for retrospective biodosimetry.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1469918/
https://www.ncbi.nlm.nih.gov/pubmed/9467057
work_keys_str_mv AT lucasjn chromosometranslocationsabiomarkerforretrospectivebiodosimetry